PUBLISHER: DelveInsight | PRODUCT CODE: 1397179
PUBLISHER: DelveInsight | PRODUCT CODE: 1397179
Blood Flow Measurement Devices Market By Product (Ultrasound Devices [Ultrasound Doppler And Transit-Time Flow Meters] And Laser Doppler Flow Meter), Application (Invasive And Non-Invasive), End-User (Hospitals, Ambulatory Surgical Centers, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the increasing prevalence of cardiovascular diseases and the rising demand of biodegradable blood flow sensors across the globe.
The global blood flow measurement devices market is estimated to grow at a CAGR of 9.1% during the forecast period from 2023 to 2028. The demand for blood flow measurement devices is being boosted due to the rising cases of various cardiovascular diseases, diabetes, and other chronic diseases across the globe. Further, the increasing number of cardiovascular surgeries, laparoscopic surgery, and other surgeries along with the advancements in product technologies, rising geriatric population base, rising product launches and approvals, among others are also contributing to the overall growth of the blood flow measurement devices market during the forecast period from 2023-2028.
The blood flow measurement devices market is witnessing a growth in product demand owing to various factors, one of the key factors is the increase in the prevalence of cardiac diseases such as stroke, heart attack, and others.
For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, every year, about 805,000 people in the United States have a heart attack, and out of these, 605,000 people suffer from their first heart attack and nearly 200,000 cases happen to people who already had a heart attack. Blood flow monitoring devices play a crucial role in managing heart attack patients, allowing healthcare providers to assess the effectiveness of interventions, monitor healing progress, and optimize treatment strategies. Thus, the demand for blood flow monitoring devices is expected to increase with the increasing prevalence of cardiovascular diseases as they contribute to better cardiovascular care, personalized treatment, and improved outcomes in individuals at risk of heart attacks.
According to the Organization for Economic Co-operation and Development (OECD) 2023, in 2021 the cases of laparoscopic appendectomy in Denmark were 7064 and the cases of laparoscopic cholecystectomy were 7672. Laparoscopic surgeries, often require precise manipulation of tissues and organs, which can potentially impact blood flow in the surgical site. To ensure optimal patient outcomes, surgeons need accurate real-time information on blood flow during these procedures, ultimately increasing the demand for blood flow measurement devices, and thereby propelling the overall market of blood flow measurement devices in the market.
The market for blood flow device measurement is expanding as a result of several research and development studies that concentrate on cutting-edge blood flow measurement devices. For instance, a novel, reasonably priced blood flow meter devised by a group of researchers at the Sree ChitraTirunal Institute for Medical Sciences and Technology was addressed by the Government of India's Ministry of Science & Technology. The researchers claimed that the palm-sized device complies with national and international standards and guidelines and is manufactured using components sourced from well-established supply chains domestically. It measures blood flow rate using a novel magnetic method and a signal conditioning technique.
Therefore, the above-mentioned factors are contributing to the growth of the blood flow measurement devices market during the forecast period from 2023-2028.
However, the high cost of the device, accuracy or false result concerns, and others may restrict the blood flow measurement device's market growth.
Blood flow measurement devices market by Product (Ultrasound Devices [Ultrasound Doppler and Transit-Time Flow Meters] and Laser Doppler Flow Meter), Application (Invasive and Non-Invasive), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the application segment of the blood flow measurement device non-invasive blood flow category is expected to amass significant revenue share in the year 2023. This can be due to the significant advantages of non-invasive techniques.
These devices provide a non-invasive method of measuring blood flow, eliminating the need for invasive procedures and reducing patient discomfort and potential complications. The convenience and ease of use associated with non-invasive blood flow meters make them suitable for a wide range of healthcare professionals and medical disciplines.
Additionally, because they offer a patient-centric approach to healthcare, their capacity to increase patient comfort and happiness contributes to their expanding demand. Thus, increased demand for non-invasive blood flow meters is being driven positively by the benefits of convenience, patient comfort, adaptability, and alignment with preventative healthcare across a range of medical specializations and healthcare settings.
Furthermore, coupled with the factors mentioned above, strategic activities such as product launches and approvals will also increase the demand for non-invasive blood flow meters. For instance, in March 2020, the FDA approved a flow patch, a non-invasive cardiovascular blood flowmeter, by Flosonics Medical. FloPatch is the world's first wireless, wearable Doppler ultra-sound system that helps clinicians better manage intravenous (IV) fluid therapy earlier in the sepsis care pathway. Thus, such strategic steps help to increase the demand for non-invasive blood flow meter devices.
Therefore, the advantages offered by non-invasive blood flow measurement devices, increasing product launches and approvals, and others are predicted to contribute to the increasing demand for this category, thereby driving the growth of the overall blood flow measurement devices market during the forecast period.
Among all the regions, North America is estimated to account for the largest share in the blood flow measurement devices market in the year 2022 owing to key growth factors such as the rising prevalence of coronary heart diseases, increasing number of surgeries, and others. Additionally, the rise in the adoption of highly advanced techniques and systems in the manufacturing of blood flow measurement devices, the increasing product launches, surging technological advancements, and others are driving the North American blood flow measurement devices market. Furthermore, sophisticated healthcare infrastructure, regulatory approval for new products, and others also helped the market growth in this region.
As per the Department of Health New York State (2020), coronary heart disease (CHD) is the most common type of heart disease, killing approximately 382,820 people annually, in the US. Also, every year about 805,000 Americans have a heart attack. The source also stated that an estimated 18.9% of New Yorkers aged 65 and older reported having some type of Cardiovascular Disease (CVD) in 2020. Blood flow monitoring devices provide valuable information about the rate, velocity, and quality of blood flow, allowing healthcare professionals to evaluate the severity of arterial blockages, monitor the effectiveness of interventions, and guide treatment decisions that can manage life-threatening conditions in cardiovascular illness. Thus, the demand for blood flow monitoring devices is increasing as a result of the rising frequency of cardiovascular illnesses.
Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in June 2023, US-based digital health company STAT Health introduced a 24/7 in-ear wearable general wellness product that measures blood flow to the head to allow a better understanding of conditions in the body that occur upon standing. Therefore, such strategic steps help to increase the demand for blood flow monitoring devices in the North America region.
Therefore, the factors mentioned above help in boosting regional product demand. Thereby, driving the North American blood flow measurement devices market forward during the forecast period.
Some of the key market players operating in the blood flow measurement devices market include: Cook, Medistim, Compumedics Limited, Permed AB, Deltex Medical Limited, Koninklijke Philips N.V., Getinge, Arjo, ATYS Medical, Moor Instruments Limited, Medtronic, AKW Medical, Inc., D. E. Hokanson, Inc., ELCAT GmbH, Oxford Optronix, QT Medical Inc. Transonic, Carolina Medical Electronics, ADINSTRUMENTS, STAT Health Informatics, Inc., and others.